Results 241 to 250 of about 113,624 (330)
Scoliosis in spinal muscular atrophy in the era of disease-modifying therapy: a scoping review. [PDF]
Gnazzo M+5 more
europepmc +1 more source
ABSTRACT Drug development in pediatric rare diseases is complicated by practical and ethical constraints on clinical trial design, stemming from small, highly heterogeneous, and vulnerable patient populations. Virtual patients (VPs) created with machine‐learning (ML), mechanistically driven computational approaches, or hybrids thereof, have the ...
Fianne Sips+9 more
wiley +1 more source
Neonatal spinal muscular atrophy with brain magnetic resonance imaging hypersignal: a case report. [PDF]
Jieda X+5 more
europepmc +1 more source
Abstract Rapid eye movement (REM) sleep is a unique brain state crucial for emotion, memory, and plasticity. Unlike well‐understood non‐REM (NREM) sleep homeostasis, REM sleep homeostasis remains less clearly defined. This review highlights recent progress in understanding REM sleep homeostasis, focusing on its neurophysiological markers, neural ...
Ting He
wiley +1 more source
Adiponectin and Leptin-Considerations in Adult Patients with Spinal Muscular Atrophy Type 3. [PDF]
Miletić M+7 more
europepmc +1 more source
Nanozymes emerge as promising therapeutic agents for reactive oxygen species (ROS)‐dependent diseases, offering advantages over traditional biocatalysts through enhanced stability, tunability, and targeting capabilities. This review explores their mechanisms, design strategies, and clinical progress, emphasizing precision medicine potential.
Lihong Zhou+8 more
wiley +1 more source
Spinal muscular atrophy is also a disorder of spermatogenesis. [PDF]
Magot A+24 more
europepmc +1 more source